We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
1751
Charles Schwab
SCHW
$181B
| $249K | ﹤0.01% |
6,300
-29,001
| -82% | -$1.04M |
|
1752
TransAlta
TAC
$4.25B
| $249K | ﹤0.01% |
+45,100
| New | +$216K |
|
|
INSY
1753
DELISTED
Insys Therapeutics, Inc.
INSY
| $249K | ﹤0.01% |
+27,106
| New | +$306K |
|
1754
CALL
Akamai
AKAM
$16.4B
| $247K | ﹤0.01% |
+3,700
| New | +$236K |
|
|
1755
PUT
Akamai
AKAM
$16.4B
| $247K | ﹤0.01% |
+3,700
| New | +$236K |
|
|
UAM
1756
DELISTED
Universal American Corp
UAM
| $247K | ﹤0.01% |
+24,799
| New | +$218K |
|
1757
Central Garden & Pet Co Class A
CENTA
$2.39B
| $246K | ﹤0.01% |
+9,968
| New | +$216K |
|
|
ELME
1758
Elme Communities
ELME
$144M
| $245K | ﹤0.01% |
7,503
-24,875
| -77% | -$759K |
|
1759
Gentex
GNTX
$4.88B
| $245K | ﹤0.01% |
12,400
-22,666
| -65% | -$413K |
|
|
SPN
1760
DELISTED
Superior Energy Services, Inc.
SPN
| $245K | ﹤0.01% |
+1,452
| New | +$242K |
|
|
EXAS
1761
DELISTED
Exact Sciences
EXAS
| $244K | ﹤0.01% |
+18,300
| New | +$295K |
|
|
CONN
1762
DELISTED
Conn's Inc.
CONN
| $244K | ﹤0.01% |
+19,240
| New | +$212K |
|
1763
CALL
Kohl's
KSS
$2.1B
| $242K | ﹤0.01% |
4,900
-26,800
| -85% | -$1.33M |
|
|
VRTV
1764
DELISTED
VERITIV CORPORATION
VRTV
| $242K | ﹤0.01% |
4,500
+186
| +4% | +$9.64K |
|
1765
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $241K | ﹤0.01% |
+800
| New | +$231K |
|
1766
Novartis
NVS
$297B
| $240K | ﹤0.01% |
+3,683
| New | +$239K |
|
1767
Monolithic Power Systems
MPWR
$65.8B
| $238K | ﹤0.01% |
2,895
-10,109
| -78% | -$812K |
|
|
SGI
1768
Somnigroup International
SGI
$15.3B
| $238K | ﹤0.01% |
13,944
-63,680
| -82% | -$951K |
|
1769
Grupo Cibest SA
CIB
$20.9B
| $237K | ﹤0.01% |
+6,472
| New | +$236K |
|
1770
Enel Chile
ENIC
$6.05B
| $237K | ﹤0.01% |
+52,000
| New | +$250K |
|
|
ARGO
1771
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $237K | ﹤0.01% |
4,139
-2,186
| -35% | -$117K |
|
1772
CBRE Group
CBRE
$42.1B
| $236K | ﹤0.01% |
7,496
-34,843
| -82% | -$1.01M |
|
|
CHMT
1773
DELISTED
Chemtura Corporation
CHMT
| $233K | ﹤0.01% |
+7,019
| New | +$232K |
|
|
EDE
1774
DELISTED
Empire District Electric
EDE
| $233K | ﹤0.01% |
6,828
-9,843
| -59% | -$337K |
|
1775
Avient
AVNT
$3.34B
| $231K | ﹤0.01% |
7,198
-6,805
| -49% | -$219K |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
BWP
MC
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.